NASDAQ · Financial Statements
Calliditas Therapeutics AB (publ) (CALT) Financial Statements
$40.00
NASDAQ: CALT
Market Cap $2.15B
Overview Financials Dividend Calliditas Therapeutics AB (publ) most recently reported annual revenue of $1.2B, net profit of $-466.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2019 2020 2021 2022 2023 Revenue $185.0M $1.0M $229.0M $803.0M $1.2B Operating Profit $-28.0M $-380.0M $-524.0M $-422.0M $-384.0M Net Profit $-33.0M $-437.0M $-510.0M $-412.0M $-466.0M EPS $-1.76 $-19.46 $-20.04 $-15.56 $-17.38 Op Margin -15.2% -43446.2% -228.7% -52.5% -31.9%
Balance Sheet (USD)
Metric 2019 2020 2021 2022 2023 Total Assets $845.0M $1.5B $1.5B $2.0B $1.9B Total Liabilities $57.0M $250.0M $452.0M $1.2B $1.6B Cash $754.0M $996.0M $956.0M $1.2B $974.0M Borrowings $6.0M $5.0M $213.0M $729.0M $979.0M
Cash Flow (USD)
Metric 2019 2020 2021 2022 2023 Operating Cash Flow $-71.0M $-309.0M $-462.0M $-311.0M $-435.0M Investing Cash Flow $-52.0M $-345.0M $-47.0M $-8.0M $-27.0M Financing Cash Flow $-10.0M $-119.0M $-83.0M $94.0M $-27.0M Net Cash Flow $97.0M $243.0M $-41.0M $294.0M $-275.0M Free Cash Flow $-87.0M $-309.0M $-484.0M $-314.0M $-447.0M
Valuation & Return Ratios
Metric Value PEG Ratio 0.38 EV / EBITDA -56.04 FCF Yield -2.17% Quick Ratio 3.08 Interest Coverage -5.25 Return 1Y — Return 3Y — Return 5Y —
Screens featuring this stock